awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57284267-79B4BF97-0A8D-4711-A6E7-CC055E870921
Q57284267-79B4BF97-0A8D-4711-A6E7-CC055E870921
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57284267-79B4BF97-0A8D-4711-A6E7-CC055E870921
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
P2860
Q57284267-79B4BF97-0A8D-4711-A6E7-CC055E870921
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57284267-79B4BF97-0A8D-4711-A6E7-CC055E870921
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c62d49e674e1d6a062bcd0fceb86f64e0f1479a3
P2860
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.